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Background:Microsomal prostaglandin E (PGE) synthase-1 (mPGES-1) is an inducible enzyme with unknown properties
in adipose homeostasis.
Results:mPGES-1 is necessary for pre-adipocyte differentiation into beige/brite adipocytes through functional interactionwith
peroxisome proliferator-activated receptor  (PPAR).
Conclusion: A coordinate interaction between mPGES-1 and PPAR is required for white-to-brown fat conversion.
Significance: Increases in the number of beige cells in fat exerts beneficial metabolic actions.
Peroxisome proliferator-activated receptor  (PPAR) is a
ligand-activated nuclear receptor and amaster regulator of adi-
pogenesis. Microsomal prostaglandin E (PGE) synthase-1
(mPGES-1) is an inducible enzyme that couples with cyclooxy-
genase-2 for the biosynthesis of PGE2. In this study we demon-
strate the existence of a coordinate functional interaction
betweenPPAR andmPGES-1 in controlling the process of pre-
adipocyte differentiation in white adipose tissue (WAT). Adi-
pocyte-specific PPAR knock-out mice carrying an aP2 pro-
moter-driven Cre recombinase transgene showed a blunted
response to the adipogenic effects of a high fat diet. Pre-adi-
pocytes from these knock-out mice showed loss of PPAR and
were resistant to rosiglitazone-inducedWATdifferentiation. In
parallel, WAT from these mice showed increased expression of
uncoupling protein 1, a mitochondrial enzyme that dissipates
chemical energy as heat. Adipose tissue from mice lacking
PPAR also showed mPGES-1 up-regulation and increased
PGE2 levels. In turn, PGE2 suppressed PPAR expression and
blocked rosiglitazone-induced pre-adipocyte differentiation
toward white adipocytes while directly elevating uncoupling
protein 1 expression and pre-adipocyte differentiation into
mature beige/brite adipocytes. Consistently, pharmacological
mPGES-1 inhibition directed pre-adipocyte differentiation
toward white adipocytes while suppressing differentiation into
beige/brite adipocytes. This browning effect was reproduced in
knockdown experiments using a siRNA directed against
mPGES-1. The effects of PGE2 on pre-adipocyte differentiation
were not seen inmice lacking PPAR in adipose tissue andwere
not mirrored by other eicosanoids (i.e. leukotriene B4). Taken
together, these findings identify PGE2 as a key regulator of
white-to-brown adipogenesis and suggest the existence of a
coordinate regulation of adipogenesis between PPAR and
mPGES-1.
The formation of new adipocytes from precursor cells is a
crucial aspect in controlling normal adipose tissue function (1,
2). During the adipogenic process, adipocytes differentiated
from mesenchymal stem cells give rise to two main types of
adipose tissue: WAT,3 characterized by the presence of adi-
pocytes containing large unilocular lipid droplets, and BAT,
composed by multiloculated adipocytes containing large num-
bers ofmithocondria (1, 2).WAT is the predominant fat type in
human adults and is widely distributed through the body; its
main function is to store excess energy as triglycerides (1, 2).
WAT is not only important for energy storage but also as an
endocrine organ because it regulates whole body homeostasis
by secreting adipokines (cytokines, chemokines, and growth
factors) and biologically active lipid mediators (3, 4). By con-
trast, BAT is located in discrete pockets and is specialized to
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generate heat by dissipating chemical energy, counteracting
hypothermia, obesity, and diabetes (1, 5). Apart from “classical”
brown adipocytes that reside in BAT depots, another type of
brown adipocytes, called beige or brite (brown-in-white) adi-
pocytes, are sporadically found in WAT upon prolonged cold
exposure or in response to -adrenergic or thiazolidinedione
exposure (1, 5, 6). Importantly, increases in the number of beige
adipocytes inWAT are associated with protection against diet-
induced obesity and metabolic diseases (7–9).
Adipocyte differentiation requires expression of peroxisome
proliferator-activated receptor  (PPAR), a member of the
nuclear receptor superfamily that functions as a ligand-acti-
vated transcription factor regulating the genes implicated in
adipogenesis (10). Although PPAR functions as a master reg-
ulator of adipocyte differentiation and is absolutely necessary
for both white and brown fat cell development (11, 12), the
mechanisms underlying terminal differentiation of pre-adi-
pocytes into white or brown adipocytes up-stream and/or
downstream from this transcription factor have not been com-
pletely elucidated.
Microsomal prostaglandin E (PGE) synthase-1 (mPGES-1) is
an inducible enzyme that cooperates with cyclooxygenase-2
(COX-2) in the biosynthesis of PGE2, one of the most ubiqui-
tous and biologically active endogenous lipid mediators (13).
Several studies have linked this lipidmediator to the adipogenic
program, although their results have yielded controversial
views. For example, PGE2 is recognized as a negative regulator
ofWAT lipolysis and adipocyte development (14, 15), and pre-
adipocytes stably transfected with either COX-1 or COX-2
show lower PPAR expression (16). Consistent with this view,
mice genetically deficient for mPGES-1 show basal elevations
in PPAR expression and transcriptional activity (17). How-
ever, more recent studies have shown that transgenic mice
overexpressing COX-2 do not exhibit changes in PPAR
expression in adipose tissues (18), although PPAR expression
has been shown to be significantly reduced in adipose tissue
from COX-2-deficient mice (19). The existence of this unde-
fined role of the COX-2/mPGES-1/PGE2 pathway in WAT
physiology led us to investigate the functional interaction
between PPAR and mPGES-1 in the process of adipogenesis.
Our results demonstrate that removing PPAR specifically in
fat cells triggers mPGES-1 expression and PGE2 biosynthesis,
uncovering an important role in the browning process ofWAT
pre-adipocytes.
EXPERIMENTAL PROCEDURES
Reagents—Rosiglitazone, prostaglandin E2 (PGE2) and leuk-
otriene B4 (LTB4) and PGE2 EIA kits were fromCaymanChem-
icals (Ann Arbor, MI). 15-Deoxy-12,14-PGJ2 (15d-PGJ2) EIA
was from Assay Designs (Ann Harbor, MI). The mPGES-1
inhibitor benzo[g]indol-3-carboxylate was synthesized and
pharmacologically characterized by Dr. Oliver Werz (Univer-
sity of Jena, Jena, Germany). Krebs-Ringer bicarbonate buffer,
DMEM, and fatty acid-free BSA were from Sigma. Nylon mesh
filters (100 m) were from BD Biosciences. TRIzol was from
Invitrogen, and L-glutamine was from Biological Industries
(Kibbutz Beit Haemek, Israel). FBS and Dulbecco’s PBS with
(/) and without (/) calcium and magnesium were from
Lonza (Vervieres, Belgium). Lab-TeK Chamber Slides were
fromNalgeNunc International (Rochester,NY). TaqManGene
Expression Assays were from Applied Biosystems (Foster City,
CA). Anti-Dlk/Pref-1 Antibody was fromMBL (Woburn,MA).
Mice—Mice carrying the loxP-targeted PPAR gene
(PPARf/f) were crossed with transgenic mice expressing Cre
recombinase under the control of the aP2 promoter to yield
adipocyte-specific PPAR KOmice (adip) (20). aP2 is an adi-
pose-specific gene that is also expressed in undifferentiated adi-
pogenic progenitors (21, 22). The control group included wild-
type (WT) mice carrying the loxP-targeted PPAR gene. Mice
were housed on wood-chip bedding cages at a ratio of 4 mice
per cage with a humidity level of 50–60% and a 12-h light-dark
cycle and were given free access to food and water. Genomic
DNA frommouse ear was isolated using the Omni-Pure Tissue
Genomic DNA Purification System (Gene Link, Hawthorne,
NY) following the manufacturer’s protocol. Mice were geno-
typed by a multiplex PCR, which was performed in a total of 20
l containing 1 l of DNA, 2 l of 10 reaction buffer (2.5 mM
MgCl2), 3.2 l of 1.25 mM dNTPs, 0.5 units of PRIMEHotMas-
ter TaqDNA Polymerase (5 PRIME, Hamburg, Germany), and
0.2–0.75 M 6-carboxyfluorescein and NED (2-chloro-5-
fluoro-7,8-fused phenyl-1.4-dichloro-6-carboxyfluorescein)
fluorescent-labeled primers (supplemental Table 1). PCR sam-
ples were amplified at 94 °C (30 s), 60 °C (30 s), and 71.5 °C (90
s) for 40 cycles in a GeneAmp PCR System 9700, and PCR
products were analyzed by capillary electrophoresis in a 3130
Genetic Analyzer (Applied Biosystems). Genotyping was also
performed by conventional PCR in a total volume of 20 l con-
taining 1 l of DNA, 2 l of 10 reaction buffer (2.5 mM
MgCl2), 3.2 l of 1.25 mM dNTPs, 1 l of unlabeled primers,
and 0.5 units of PRIME HotMaster TaqDNA polymerase. PCR
samples were amplified as described above, and products were
analyzed by electrophoresis in 2.5% LM Sieve-agarose gels and
visualized by GelRedTM Nucleic Acid Gel Stain (Biotium, Hay-
ward, CA) using a 100-bp DNA ladder marker (Invitrogen).
The mice used in the study were F5 or subsequent genera-
tions of age-matched littermates. To induce obesity, male WT
and adip mice were fed a high fat diet (HFD) (60% Kcal from
fat; Research Diets Inc., New Brunswick, Canada) for 12 weeks
starting at week 6 of age. The chow group received a standard
pelleted chow diet (13% kcal from fat) for 12 weeks. At the end
of the study mice were euthanized under ketamine/xylazine
(4:1) anesthesia via intraperitoneal injection (Ketolar, Parke
Davis-Pfizer, Dublin, Ireland; Rompun, Bayer Leverkusen, Ger-
many). Epididymal WAT (eWAT) and interscapular BAT
(iBAT) were collected and snap-frozen in liquid nitrogen for
further analysis. All animal studies were conducted in accord-
ance with the criteria of the Investigation and Ethics Commit-
tee of Hospital Clinic and the European Community laws gov-
erning the use of experimental animals.
Ex Vivo Experiments in eWAT Explants—Fat pads were col-
lected under sterile conditions and placed in P60 plates in pre-
warmed (37 °C) DPBS/ containing penicillin (100 units/ml)
and streptomycin (100 mg/ml). Connective tissue and blood
vessels were removed by dissection before cutting the tissue
into small pieces. Explants were washed with DPBS at 37 °C by
centrifugation for 1 min at 400  g to remove blood cells and
mPGES-1 Controls Pre-adipocyte Differentiation
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pieces of tissue containing insufficient adipocytes to float as
described in Refs. 23 and 24. Thereafter, explants were cultured
in 12-well plates (40mg/well) withDMEM, L-glutamine (2mM),
penicillin (50 units/ml), streptomycin (50 mg/ml), and 2% fatty
acid-free BSA and incubated with vehicle (0.04% ethanol),
PGE2 (1 M), the mPGES-1 inhibitor benzo[g]indol-3-carbox-
ylate (1, 5, and 10M), the selective COX-1 inhibitor SC-560 (1
and 5M), the selective COX-2 inhibitors SC-58635 (5M) and
SC-236 (1 M), and the selective 5-lipoxygenase (5-LO) inhibi-
tor CJ-016 (1 M) for 12 h. Supernatants were collected and
kept at80 °C.
Analysis of Eicosanoids by Enzyme Immunoassay (EIA) and
LC-Electrospray Ionization-MS/MS—LTB4, PGE2 and 15d-
PGJ2 levels were extracted from eWAT samples (200 mg) from
WT and adip mice. Each sample was individually homoge-
nized in a Pellet pestle, CordlessMotor (Sigma) in 400l of cold
MeOH and kept at 80 °C overnight. Subsequently, homoge-
nates were centrifuged at 2000 rpm for 10 min at 4 °C. Super-
natants were collected and brought to a final volume of 10 ml
with distilled water, transferred into syringes, acidified to pH
3.5, and loaded onto Sep-Pak C18 Cartridges (Waters, Milford,
MA). Materials were eluted with methyl formate, evaporated,
and resuspended in EIA buffer. Confirmation of PGE2 and 15d-
PGJ2 levels and analysis of 6-keto-PGF1, PGF2, PGD2, PGJ2,
and thromboxane B2 concentrations were performed by LC-
electrospray ionization-MS/MS analysis. Briefly, 50 mg of fro-
zen adipose tissue were extracted on solid phase columns
before injection into an Agilent 1200 HPLC system coupled
with an Agilent 6460 Triplequad mass spectrometer with elec-
trospray ionization source. Analysis of lipid mediators was per-
formed with MRM in negative mode.
Analysis of Gene Expression—Total RNA was isolated using
theTRIzol reagent. RNAconcentrationwas assessed in aNano-
Drop-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE), and its integrity was tested with a RNA 6000
NanoAssay in a Bioanalyzer 2100 (Agilent Technologies, Santa
Clara, CA). cDNA synthesis from 0.5–1.0 g of total RNA was
performed using theHigh Capacity cDNAArchive kit (Applied
Biosystems). Quantitative analysis of gene expression was per-
formed by real-time PCR in an ABI Prism 7900 Sequence
Detection System in Fast Real Time System. Optimal and pre-
designed TaqMan Gene Expression Assays were used (TNF-
(ID Mm00443258_m1), PPAR (ID Mm00440945_m1), 5-LO
(ID Mm001182747_m1), 5-LO-activating protein FLAP (ID
Mm00802100_m1), COX-2 (ID Mm00478374_m1), mPGES-1
(ID Mm00460181_m1), PGD2 (ID Mm01330613_m1), 15-pros-
taglandin dehydrogenase (15-PGDH) (ID Mm0051521_m1),
PPAR co-activator-1  (PGC-1; ID Mm01208835_m1),
PPAR isoform2 (ID Mm00440940_m1), mPGES-2 (ID
Mm00460181_m1), Cidea (ID Mm00432554_m1), uncoupling
protein 1 (UCP1; ID Mm01244861_m1), PRD1-BF-1-RIZ1
homologous domain containing protein-16 (PRDM16; ID
Mm00712556_m1)) and custom TaqMan Assay PPAR iso-
form1 (NCBI NM_001127330.1) as previously described (20).
-Actin (Actb; ID Mm00607939_s1) was used as an endoge-
nous control. PCR results were analyzed with the Sequence
Detector Software Version 2.1 (Applied Biosystems). Relative
quantification of gene expression was performed using the
comparativeCtmethod. The amount of target gene normalized
to -actin and relative to a calibrator was determined by the
arithmetic equation 2Ct described in the comparative Ct
method.
Isolation of Pre-adipocytes from the eWAT Stromal Vascular
Cell (SVC) Fraction—eWAT was excised, weighed, rinsed
twice in cold carbogen-gassed Krebs-Ringer supplemented
with 1% fatty acid-free BSA and 2mM EDTA and centrifuged at
500  g for 5 min at 4 °C to remove free erythrocytes and leu-
kocytes. Tissue suspensions (300–600 mg) were placed in 5 ml
of digestion buffer containingKrebs-Ringer supplementedwith
1% fatty acid-free BSA and 1 mg/ml collagenase A (Roche
Applied Science) and incubated at 37 °C for 30min as described
(23). Cell pellets corresponding to the SVCwere incubatedwith
erythrocyte lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, and 0.1
mM EDTA) for 5min and centrifuged at 500 g for 5min. SVC
with a predominant population of pre-adipocytes (72%) were
further enriched using the magnetic labeling system Lineage
Cell Depletion kit (Miltenyi Biotech, Auburn, CA), which
depletes mature hematopoietic cells, such as monocytes/
macrophages, T cells, B cells, granulocytes, and erythrocytes
and their committed precursors in the SVC fraction. Pre-adi-
pocyte purity was tested by immunocytochemistry of Pref-1,
which is expressed specifically in pre-adipocytes but not in
mature adipocytes.
Pref-1 Immunocytochemistry—After cytospin at 500 g for 5
min, cells on coverslips were fixed with acetone for 10 min at
20 °C followed by incubation with peroxidase blocking solu-
tion (S2023, DAKO, Glostrup, Denmark) for 15 min at room
temperature to block endogenous peroxidase activity. After
washing with DPBS, cells were incubated with blocking serum
(Vectastin ABC Kit, Vector Laboratories, Burlingame, CA).
Cellswere then incubated overnight at 4 °Cwith the primary rat
anti-mouse Pref-1 antibody (1/250) followed by incubation for
30 min at room temperature with a biotinylated rabbit anti-rat
IgG secondary antibody and incubation with ABC for 30min at
room temperature as described (25). Colorwas developed using
the diaminobenzidine substrate (Roche Applied Science), and
cells were counterstained with hematoxylin and mounted with
aqueous solution. Cells were visualized at magnification 200
in a Nikon Eclipse E600 microscope (Kawasaki, Japan).
Pre-adipocyte Differentiation into White Adipocytes—Freshly
isolated pre-adipocytes were seeded onto 96-well plates (40,000
cells/well) with DMEM supplemented with 10% FBS and 10
ng/ml basic FGF (R&D Systems, Minneapolis, MN) and main-
tained in a 5% CO2 atmosphere. Cells were allowed to grow to
confluence for 2 days and then exposed to the white adipocyte
differentiation mixture (25) (1 g/ml insulin, 0.25 g/ml dexa-
methasone, 0.5 mM isobutylmethylxanthine, and 1 M rosigli-
tazone) with 100 units/ml penicillin/streptomycin and 2 mM
L-glutamine in the presence of vehicle (0.01% ethanol), PGE2
(0.1 or 1M), SC-560 (3M), SC-58635 (3M), and benzo[g]in-
dol-3-carboxylate (3 M). After 72 h, cells were grown in fresh
DMEM with 10% FBS until day 12 for harvesting. Mature adi-
pocytes were fixed in 4% paraformaldehyde for 1 h and then
with 60% isopropyl alcohol before incubation with 0.2% Oil
Red-O for 30 min at room temperature. To quantify the
amount of Oil Red-O retained by the cells, cells were incubated
mPGES-1 Controls Pre-adipocyte Differentiation
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with isopropyl alcohol for 30 min with shaking to elute the
stain, and the optical density was measured at 500 nm in a
FluoStar Optimamicroplate reader (BMG Labtech, Offenburg,
Germany). For visualization, cells were counterstained with
Gill’s hematoxylin, washed with distilled water (4%), and
mountedwith aqueous solution. Cells were visualized at amag-
nification of200 in a Nikon Eclipse E600 microscope.
Pre-adipocyte Differentiation into Beige/Brite Adipocytes—
Freshly isolated eWAT pre-adipocytes were cultured and
grown to confluence as indicated before and then exposed to
the beige adipogenic mixture (26, 27) containing insulin (5
g/ml), dexamethasone (0.5 M), isobutylmethylxanthine (0.5
mM), 3,5,3-triiodothyronine (T3) (1 nM), rosiglitazone (1 M),
penicillin/streptomycin (100 units/ml), and L-glutamine (2
mM). Cells were incubated with vehicle (0.01% ethanol), PGE2
(0.1 M), SC-560 (3 M), SC-58635 (3 M), and benzo[g]indol-
3-carboxylate (3 M) for 48 h. The induction medium was
replaced with fresh DMEM containing 10% FBS, 1 g/ml insu-
lin, and 1 nM T3 for 2 additional days. Thereafter, cells were
incubated in DMEMwith 10% FBS until day 10. Differentiation
of pre-adipocytes into beige/brite adipocytes was evaluated by
assessing the mitochondrial distribution using MitoTracker
Red CMXRos kit (Invitrogen). The MitoTracker Red CMXRos
reagent was diluted in DMSO at 100 nM and incubated for 30
min at 37 °C. The adipocytes were washed with DPBS/ and
fixed with 4% (w/v) formaldehyde for 15 min before mount-
ing with Vectashield medium containing DAPI (Molecular
Probes, Eugene, OR). Mitochondrial distribution was exam-
ined under a fluorescence microscope (Olympus BX51,
Hamburg, Germany).
Differentiation of 3T3-L1 Adipocytes—Mouse 3T3-L1 cells
were maintained in DMEM supplemented with 10% (v/v) FBS
and 100 units/ml penicillin/streptomycin. Cells were main-
tained in a humidified atmosphere of 5% CO2 at 37 °C and dif-
ferentiated into white or beige adipocytes as described before.
siRNA Transfection—Synthetic mPGES-1 siRNA and Uni-
versal Scrambled Negative Control (siCON) oligonucleotides
were designed and synthesized by OriGene (Rockville, MD).
3T3-L1 cells were transfected at 70% confluence with 10 nM
siRNA using Metafectene PRO (Biontex, Martinsried, Ger-
many) at a 1:3 (w/v) in 24-well plates according to the manu-
facturer’s instructions. To assess siRNA efficiency, RNA and
protein samples were obtained after 48 h. Three different
siRNAs targeting mPGES-1 were screened (data not shown),
and the sequence of the most efficient was used. The effects of
mPGES-1 siRNA on adipocyte differentiation were assessed 4
days after the addition of the differentiation mixture.
Western Blotting—Total protein from adipose tissue was
extracted in lysis buffer containing 50 mM HEPES, 20 mM
-glycerophosphate, 2 mM EDTA, 1% Igepal, 10% glycerol, 1
mMMgCl2, 1 mMCaCl2, and 150mMNaCl, supplemented with
protease inhibitor (Complete Mini) and phosphatase inhibitor
(PhosSTOP) cocktails. For protein isolation from cell cultures,
cells were scraped into ice-cold DPBS and resuspended in 150
l of lysis buffer. Homogenates from tissues were incubated on
ice for 15 min and centrifuged at 16,000 g for 20 min at 4 °C.
Homogenates from cells were incubated on ice for 10 min and
centrifuged at 1000 rpm for 2min. Supernatantswere collected,
and COX-1, COX-2, and mPGES-1 protein expression was
analyzed by Western blot. A total of 60 g of protein from
tissues and 30 g of protein from cells were resuspended in
SDS-containing Laemmli sample buffer, heated for 5 min at
95 °C, and resolved on 8% (tissue) or 15% (cells) SDS-PAGE.
Proteins were electroblotted for 60–90 min at 100 V at 4 °C
onto polyvinyl difluoride membranes. Transfer was performed
by the iBlot Dry Blotting System (Invitrogen) at 20 V in 7 min.
The transfer was visualized by Ponceau S solution. Membranes
were then soaked for 1 h at room temperature in TBS (20 mM
Tris/HCl, pH 7.4, and 0.5 MNaCl) containing 0.1% (v/v) Tween
20 (0.1% TBS-T) and 5% (w/v) nonfat dry milk. Blots were
washed 3 times for 5 min each with 0.1% TBS-T and subse-
quently incubated overnight at 4 °C with primary mouse anti-
mouseCOX-1 (dilution 1:300), rabbit anti-mouseCOX-2 (dilu-
tion 1:1000), and rabbit anti-mouse mPGES-1 (dilution 1:150)
antibodies (Cayman Chemicals) and primary anti-mouse
GAPDH (dilution 1:1000) (Abcam, Cambridge, UK) in 0.1%
TBS-T containing 5%BSA.After washing the blots 3 times for 5
min each with 0.1% TBS-T, membranes were incubated for 1 h
at room temperature with an HRP-linked donkey anti-rabbit
secondary (dilution 1:2000) antibody (Biolegend, San Diego,
CA) in 0.1% TBS-T (for COX-2 and GAPDH) and HRP-linked
anti-mouse IgG (dilution 1:2000) (Cell Signaling, Danvers,MA)
in 0.1% TBS-T for COX-1. Bands were visualized using the EZ-
ECL chemiluminescence detection kit (Biological Industries) in
a LAS 4000 imaging system (GE Healthcare) and quantified
using Image GE ImageQuant TL analysis software.
RESULTS
Mice lacking PPAR specifically in adipocytes were gener-
ated by introducing transgenicCre recombinase under the con-
trol of the aP2 promoter into mice homozygous for the loxP-
flanked (floxed) allele of PPAR. The presence of respective
cell-specific Cre recombinase transgenes was confirmed by
DNA genotyping, which showed either a 210-bp band corre-
sponding to WT mice carrying the loxP-targeted PPAR gene
or 210- and 524-bp bands corresponding to the presence of
both floxed alleles and aP2-Cre recombinase (supplemental Fig.
1). Consistent with earlier studies showing that30% of cells in
adipose tissue are nonfat cells (21, 28), expression of PPAR
isoforms 1 and 2 was reduced in base-line conditions by
47–61% in eWAT from adipocyte-specific PPAR knock-out
(adip) mice (Fig. 1A). Because PPAR is a master regulator of
adipocyte differentiation, we used the HFD model to induce
obesity inWT and adip mice. As shown in Fig. 1B, ablation of
PPAR isoforms in adip mice under HFD feeding ranged
between 63 and 65%. HFD feeding by itself produced a signifi-
cant reduction in PPAR1 but not in PPAR2 in both WT and
adip mice (supplemental Fig. 2). Compared with WT mice,
adip mice showed a lesser body weight gain (Fig. 1C) and
reduced eWAT weight (Fig. 1D) in response to HFD feeding.
Under the chow diet, adip mice showed similar body weight
gain and slightly reduced eWAT weight (Fig. 1, C and D).
To assess the effects of PPAR deletion on adipogenesis, we
compared pre-adipocyte differentiation in SVC fractions from
adip mice with those from WT mice. After depletion of
mature hematopoietic cells, 90–95% pre-adipocyte purity
mPGES-1 Controls Pre-adipocyte Differentiation
SEPTEMBER 27, 2013•VOLUME 288•NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 28233
 at Biblioteca de la U
niversitat de Barcelona on M
arch 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
was confirmed by Pref-1 immunocytochemistry (Fig. 1E). Puri-
fied pre-adipocytes from adip mice showed a greater loss of
PPAR (72%) (Fig. 1F) compared with that seen in whole
adipose tissue (Fig. 1A). Of note, pre-adipocytes from adip
mice were resistant to rosiglitazone-induced differentiation
toward white adipocytes (Fig. 1G). Interestingly, the expression
of the mitochondrial marker UCP1 was significantly up-regu-
lated in eWAT from adip mice, whereas this brown marker
was down-regulated in iBAT from these mice (Fig. 1H). As
expected, UCP1 and PGC-1were predominantly expressed in
iBAT (Fig. 1I). UCP1 expression was significantly reduced by
HFD (Fig. 1I).
PGs are key regulatory components of adipogenesis. The sta-
tus of the PGE2 biosynthetic pathway in adipose tissue in the
absence of PPAR has not been investigated. Consequently, we
next assessed the expression of the key enzymes involved in
adipose PGE2 biosynthesis inWT and adip mice. COX-2 was
found up-regulated at the protein level in adipose tissue from
adip mice under HFD but not in chow diet (Fig. 2A). No
changes in COX-2 expression were detected at themRNA level
in both conditions (data not shown). In contrast, COX-1 was
up-regulated inadipmice under the chowdiet but not inHFD
(Fig. 2B). Consistently, increased PGE2 levels were detected in
fat tissue from these KO mice either under chow or HFD con-
ditions (Fig. 2C). Further evidence on the relationship between
PGE2 and PPAR was obtained in ex vivo experiments in fat
pads. First, fat explants fromadipmice displayed a remarkable
induction in COX-2 expression (Fig. 2D). Second, the addition
of exogenous PGE2 up-regulated COX-2 in fat explants from
bothWTandadipmice (Fig. 2E), suggesting the existence of a
PPAR-independent positive regulatory feedback. Third, fat
explants from adip mice also displayed mPGES-1 up-regula-
FIGURE1.Effects of targeteddeletionofPPAR in adipocytes.A, adiposemRNAexpression for PPAR isoforms 1 and2 assessedby real-timePCR inWT (n
10) and aP2-Cre driven PPAR KO (adip) (n 9) mice under chow conditions. B, expression for PPAR isoforms 1 and 2 in eWAT fromWT (n 6) and adip
(n 6) mice after 12 weeks of HFD (60% kcal from fat) feeding. C, body weight in WT (n 5) and adip (n 4) mice receiving a chow diet and in WT (n 13)
andadip (n 11)mice during the obesity-inducedmodel of HFD feeding for 12weeks.D, eWATweight inWT (n 18) andadip (n 15)mice under Chow
and HFD conditions. E, representative photomicrographs of SVC fraction and pre-adipocyte cultures stained with Diff-quick or immunostained with Pref-1
specific antibody (200 magnification). F, PPAR expression in pre-adipocytes fromWT (n 3) and adip (n 3) mice. G, representative bright field images
of pre-adipocytes fromWT and adip mice incubated with rosiglitazone (Rosi, 1 M) or vehicle (Veh). Absorbance values from Oil Red-O staining of rosiglita-
zone-inducedpre-adipocytedifferentiation towardwhite adipocytes are shownon the right.H,mitochondrialUCP1expression ineWATand iBAT fromWT (n
17) andadip (n 11) mice. I, UCP1 and PGC-1 expression (fold change versus eWAT for each condition and gene studied) in eWAT and iBAT fromWTmice
under Chow and HFD conditions. Results are expressed as themean	 S.E. *, p
 0.05; **, p
 0.01; ***, p
 0.001 versusWTmice. #, p
 0.05 versus Veh. a, p

0.05 versus chow.
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tion (Fig. 2F). Last, the addition of exogenous PGE2 also up-reg-
ulated mPGES-1 in WT and adip fat explants (Fig. 2G).
Changes in other members of the PG cascade and biosynthetic
pathways were also detected in adip mice. Indeed, increased
15d-PGJ2 levels were elevated in these mice under chow condi-
tions but not during HFD (Fig. 2H). This was consistent with
increased prostaglandin D synthase (PGDS) expression in
adip mice only under Chow diet (Fig. 2I). Moreover, adip
mice showed reduced mPGES-2 expression (Fig. 2K) without
changes in 15-prostaglandin dehydrogenase, the enzyme that
catalyzes the dehydrogenation of active PGE2 (Fig. 2K).
Another COX-derived product analyzed by LC- electrospray
FIGURE 2. COX-2 and mPGES-1 up-regulation and increased adipose PGE2 levels in aP2-Cre driven PPAR KO (adip) mice. A, adipose tissue protein
expression for COX-2 in WT (n 8) andadip (n 8) mice under Chow and HFD conditions. B, adipose tissue protein expression for COX-1 in WT (n 9) and
adip (n 7) mice under chow and HFD conditions. C, PGE2 levels in adipose tissue fromWT (n 6) andadip (n 6) mice under chow and HFD conditions.
D, expression of COX-2 in fat explants fromWT andadipmice incubated ex vivo. E, expression of COX-2 inWT andadip fat explants incubated with vehicle
(Veh, 0.04% ethanol) and PGE2 (1 M) for 12 h. F, expression of mPGES-1 in fat explants fromWT and adip mice incubated ex vivo. G, expression of mPGES-1
inWT andadip fat explants incubated with vehicle (Veh, 0.04% ethanol) and PGE2 (1M) for 12 h. H, levels of 15d-PGJ2 in adipose tissue fromWT (n 6) and
adip (n 6) mice under chow and HFD conditions. I, expression of prostaglandin D synthase (PGDS) in these mice. J, adipose tissue mPGES-2 expression. K,
adipose tissue 15-prostaglandin dehydrogenase (15-PGDH) expression. Results are expressed as mean	 S.E. *, p
 0.05; **, p
 0.01; ***, p
 0.001 versusWT
mice. a, p
 0.05; b, p
 0.01 versus vehicle.
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ionization-MS/MS and found increased in adip mice was
PGF2 (supplemental Table 2).
To elucidate the ability of COX-derived products to regulate
the adipogenic program, we next assessed the effects of PGE2
on pre-adipocyte differentiation. Pre-adipocytes isolated from
eWAT were primed with the differentiation-inducing mixture
containing insulin, dexamethasone, isobutylmethylxanthine,
and rosiglitazone in the presence of PGE2 or vehicle, and the
differentiation toward white adipocytes was monitored by
Oil Red-O staining. As shown in Fig. 3A, PGE2 significantly
reduced rosiglitazone-induced white adipocyte differentiation.
PGE2 did not modify the Oil Red-O signal in the absence of
rosiglitazone in the differentiation mixture (Fig. 3A, inset).
Conversely, PGE2 stimulated pre-adipocytes incubated with
the brown adipocyte differentiationmixture containing insulin,
dexamethasone, isobutylmethylxanthine, T3, and rosiglitazone
FIGURE 3.Effects of PGE2onpre-adipocytedifferentiation.A, Oil Red-O staining of primary eWATpre-adipocytes at day 12 of differentiation incubatedwith
rosiglitazone (Rosi, 1 M) in the absence or presence of PGE2 (0.1 M) for 72 h. The bottom graph shows the quantification of the Oil Red-O content. Inset,
pre-adipocytes incubated with increasing concentrations of PGE2 in the absence of rosiglitazone. B, pre-adipocytes from eWAT induced to brown differenti-
ation in the absence or presence of PGE2 (0.1M) for 72 h. Cells were labeledwithMito Tracker and co-stainedwithDAPI to identify nuclei (middle panel) (200
magnification). C, morphometric quantification of the area stained with MitoTracker. D, corresponding bright-field images (200 magnification). E, UCP1
expression in pre-adipocytes fromWT (n 4) and aP2-Cre driven PPAR KO (adip) mice incubated with PGE2 (1M) or vehicle (Veh). F, mRNA expression for
PPAR isoforms 1 and 2 assessed by real-time PCR in fat eWAT explants fromWTmice incubated with PGE2 (1M) or vehicle for 12 h. Results are expressed as
the mean	 S.E. *, p
 0.05; **, p
 0.001 versus vehicle. a, p
 0.05 versus rosiglitazone.
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to induce the development of beige/brite cells, as monitored by
MitoTracker Red CMXRos (Fig. 3, B–D). Images from these
experiments are shown at a lower magnification in supplemen-
tal Fig. 3A. Interestingly, a direct stimulatory effect of PGE2 on
the brown marker UCP1 was observed in fat pads from WT
mice (Fig. 3E). In contrast, PGE2 was unable to stimulate the
browning of pre-adipocytes from adip mice lacking PPAR
(Fig. 3E). A suppression of both PPAR 1 and 2 isoforms was
observed in WT adipose tissue explants incubated with PGE2,
suggesting a negative regulation of PPAR by this eicosanoid
(Fig. 3F).
Consistent with the stimulatory role of exogenous PGE2 on
pre-adipocyte differentiation toward beige/brite adipocytes,
inhibition of endogenous PGE2 synthesis was associated with
pre-adipocyte commitment toward the WAT phenotype (Fig.
4A). The capability of inhibitors of PGE2 synthesis to induce the
FIGURE 4. Effects of PGE2 inhibition on pre-adipocyte differentiation. A, quantification of Oil Red-O staining of primary eWAT pre-adipocytes at day 12 of
differentiation incubated with 3 M selective COX-1 (SC-560), COX-2 (SC-58635), and mPGES-1 (benzo[g]indol-3-carboxylate) inhibitors (Inh) for 72 h in the
absence or presence of rosiglitazone (1M). Veh, vehicle. B, representativemicrophotographs of pre-adipocytes from eWAT induced to brown differentiation
in the absence or presence of COX-1, COX-2, or mPGES-1 inhibitors at 3 M. Cells were labeled with MitoTracker and co-stained with DAPI to identify nuclei
(200 magnification). The morphometric assessment of the area stained with MitoTracker is shown on the right. C, mRNA expression for mPGES-1 48 h after
transfectionof 3T3-L1 cellswith amPGES-1 siRNAor anuniversal scramblednegative control (siCON). Inset, protein levels formPGES-1 andGAPDHasmeasured
by Western blot. D, UCP1 expression in 3T3-L1 cells transfected with mPGES-1 siRNA and siCON or incubated with the selective mPGES-1 inhibitor ben-
zo[g]indol-3-carboxylate (3M). E, expression of PRDM16 in 3T3-L1 after genetic or pharmacological inhibition of mPGES-1. F, changes in Cidea expression in
theseexperiments.G, PGC-1expression.H, UCP1, Cidea, andPGC-1expression inprimarypre-adipocytes incubatedwith vehicle (0.04%ethanol) or selective
COX-1 (SC-560) and COX-2 (SC-58635) inhibitors (3 M). Results are expressed as the mean 	 S.E. of three individual experiments in duplicate. *, p 
 0.05;
**, p
 0.01; ***, p
 0.001 versus vehicle or siCON.
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WAT program was more evident in the presence of rosiglita-
zone in the differentiation mixture (Fig. 4A). In these experi-
ments, SC-560, a selective COX-1 inhibitor, produced similar
effects to those of SC-58635, a selective COX-2 inhibitor (Fig.
4A). By contrast, in the absence of rosiglitazone, the ben-
zo[g]indol-3-carboxylate compound, which is a potent inhibi-
tor of mPGES-1 without significant activity on COX-1/COX-2
(29), exerted a more efficacious stimulatory effect on WAT
development (Fig. 4A). Importantly, the mPGES-1 inhibitor
significantly decreased pre-adipocyte differentiation into
beige/brite cells induced by the differentiation mixture (Fig.
4B). Images from these experiments are shown at a lower mag-
nification in supplemental Fig. 3B. To discard potential off-
target actions of the mPGES-1 inhibitor, we performed knock-
down experiments using a siRNA directed against mPGES-1.
Because primary pre-adipocytes are difficult to transfect,
knockdown experiments were performed in the 3T3-L1 adipo-
genic cell line, the most studied cell line used for adipocyte
differentiation (30). As shown in Fig. 4C, both mRNA and pro-
tein expression for mPGES-1 as measured by real-time PCR
andWestern blot, respectively, were significantly reduced 48 h
after transfection. Interestingly, mPGES-1 gene silencing
reduced the expression of markers of pre-adipocyte browning
(i.e. UCP1, Cidea, and PGC-1) to a similar extent as that of
pharmacological mPGES-1 inhibition (Fig. 4, D–G). Of note,
genetic or pharmacological inhibition ofmPGES-1 reduced the
expression of the brown adipose determination factor PRDM16
(Fig. 4E). Consistent with findings described in Fig. 4B, phar-
macological inhibition of either COX-1 or COX-2 did not
translate into changes in adipocyte browning (Fig. 4H).
Consistent with previous publications, the mPGES-1 inhibi-
tor benzo[g]indol-3-carboxylate blocked PGE2 formation by
55% (Fig. 5A) (29). In addition, confirming the existence of a
negative regulatory loop between PGE2 and PPAR, fat
explants incubated with this mPGES-1 inhibitor displayed
enhanced PPAR expression (Fig. 5B). Given that changes in
pre-adipocyte browning were only seen with the mPGES-1
inhibitor despite similar suppression of PGE2 levels with selec-
tive COX-1 and COX-2 inhibitors, we next explored the
pharmacological properties of this compound on other eico-
sanoid-generating pathways. In this regard, this benzo[g]indol-
3-carboxylate compound has been shown to suppress leukotri-
ene biosynthesis by inhibiting 5-LO (31). Accordingly, we
assessed the effects of this compound on LTB4 formation by
adipose tissue. As shown in Fig. 5, C and D, this compound
inhibited LTB4 levels and 5-LO expression in a concentration-
dependent manner in fat explants fromWTmice. Noteworthy,
adip mice exhibited increased adipose LTB4 levels accompa-
nied by reduced 5-LO expression (Fig. 5E). The presence of
augmented LTB4 levels in adip mice was likely related to a
parallel increase in FLAP expression (Fig. 5E). When tested on
adip mice, the benzo[g]indol-3-carboxylate compound also
produced concentration-dependent inhibitory actions on LTB4
levels and 5-LO expression (Fig. 5, F and G). The participation
of LTB4 in the browning process was excluded by demonstrat-
ing the lack of effect of this 5-LO product on the expression of
UCP1, Cidea and PGC-1 in WAT pre-adipocytes (Fig. 5H).
Because in addition to adipogenesis, PPAR also plays a role
in regulating inflammatory response, we finally assessed the
consequences of lacking PPAR on TNF expression in fat
explants. As shown in Fig. 6A, adip mice exhibited increased
expression of TNF as comparedwith tissue explants fromWT
mice. This result was consistent with the observation that
rosiglitazone was able to down-regulate the expression of this
adipokine (Fig. 6B). Given that mPGES-1 products are well
FIGURE 5. Lackof effect of the 5-LOproduct LTB4 onpre-adipocytediffer-
entiation. A, percent (%) inhibition of PGE2 synthesis as determined by
enzyme immunoassay (EIA) inWT fat explant supernatants incubated ex vivo
at 5 M concentration with selective COX-1 (SC-560), COX-2 (SC-58635), and
mPGES-1 (benzo[g]indol-3-carboxylate) inhibitors (Inh).Veh, vehicle.B,mRNA
expression for PPAR assessedby real-timePCR in fat eWATexplants fromWT
mice incubated with increasing concentrations of the mPGES-1 inhibitor for
12h.C, effects of themPGES-1 inhibitor onLTB4productionbyeWATexplants
fromWTmice. D, effects of the mPGES-1 inhibitor on eWAT 5-LO expression.
E, LTB4 levels and5-LOand5-LO-activatingprotein (FLAP) expression ineWAT
from WT (n 10) and aP2-Cre driven PPAR KO (adip) (n 9) mice under
HFD conditions. F andG, effects of increasing concentrations of themPGES-1
inhibitor on LTB4 production and 5-LO expression in eWAT explants from
adip mice. H, representative bright-field images and UCP1, Cidea, and
PGC-1 expression in primary eWAT pre-adipocytes incubatedwith LTB4 (0.1
M) or vehicle for 48 h. Data are expressed as the mean 	 S.E. *, p 
 0.05;
**, p
 0.01; ***, p
 0.001 with respect to vehicle or WT mice.
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known lipid mediators participating in inflammatory response
(13), we also assessed the consequences of mPGES-1 inhibition
on adipose TNF expression. In fat pads from both WT and
adip mice, TNF was down-regulated in a concentration-de-
pendent manner by the pharmacological mPGES-1 inhibitor
(Fig. 6C). This finding was reproduced in knockdown experi-
ments using a siRNA directed against mPGES-1 (Fig. 6C, inset).
Similar to TNF, adip mice exhibited increased expression of
IL-6 and MCP-1 as compared with tissue explants from WT
mice (Fig. 6,D andE). These two inflammatory adipokineswere
also blocked by different selective COX and 5-LO inhibitors
(Fig. 6F).
DISCUSSION
PPAR plays a unique regulatory role in adipose tissue
homeostasis by exerting strict control of the adipogenic proc-
ess. Here we present evidence that mice lacking PPAR specif-
ically in the adipose tissue are resistant to HFD-induced eWAT
formation bymechanisms linked to PGE2 biosynthesis. Indeed,
our study demonstrates the induction of mPGES-1 expression
and augmented PGE2 levels in eWAT from aP2-Cre PPAR-
deficient mice. This mPGES-1-derived product is able to divert
pre-adipocyte differentiation inWAT fromwhite adipocytes to
beige/brite mature adipocytes accompanied by up-regulation
of UCP1. A proof of concept of themPGES-1 role was obtained
by inhibiting either the expression or the activity of this termi-
nal enzyme. In particular, the addition of a selective pharmaco-
logical mPGES-1 inhibitor as well as a siRNA directed against
mPGES-1 to adipogenic precursors resulted in the reduction of
browning markers (i.e.UCP1, Cidea, and PGC-1) and brown-
ing determination factors (i.e. PRDM16). Together, these find-
ings are relevant in terms of energy homeostasis because the
engagement of beige/brite adipocytes and the induction of a
thermogenic program in WAT depots are able to waste the
surplus of energy through increased heat production, which
ultimately exerts protection against obesity and obesity-related
co-morbidities.
Previous studies indicate that beige/brite cells emerging in
WATdepots come froma completely different cell lineage than
those in the classical BAT depots (6). To date, the beige/brite
cells in WAT depots have been described upon chronic cold
exposure or in response to -adrenergic or PPAR agonists (1,
5, 6). Our study is the first investigation providing evidence that
exposure of pre-adipocytes of WAT origin to the eicosanoid
PGE2 results in a browning effect during the adipocyte differ-
entiation process. These findings add value to the previous
observation that overexpression of COX-2, the first upstream
enzyme in the PG biosynthetic cascade, was associated with de
novo recruitment of brown adipocytes inWAT (18). Similarly, a
previous study using COX-2-deficient mice reported that
induction of UCP1 expression in WAT is dependent on COX
activity (32). However, these studies left unanswered the rela-
tive role of PGs in beige fat development and whether WAT
beige cells come from progenitor cells pushed to develop into
beige/brown fat by PGs or whether white adipocytes could
directly convert into beige cells.Moreover, these previous stud-
ies pose the limitation that in addition to PGE2, COX-2 activity
gives rise to other PGs, including PGI2 and specially PGD2.
PGD2 undergoes spontaneous dehydration to a number of
derivatives including 15d-PGJ2, which is a potent ligand for the
activation of PPAR, although its function in adipogenesis is
still unproven (33). Our study obviates these limitations by pro-
viding evidence of the direct involvement of a COX-2 down-
stream terminal synthase responsible for the biosynthesis of
PGE2 (i.e.mPGES-1), which drives beige/brite fat development
FIGURE 6.Modulation of pro-inflammatory adipokines by PPAR andmPGES-1. A, TNF expression in eWAT explants fromWT (n 6) and aP2-Cre driven
PPAR KO (adip) (n 6) mice. B, TNF expression in eWAT explants fromWTmice incubated in the absence or presence of rosiglitazone (Rosi, 10 M). Veh,
vehicle. C, effects of increasing concentrations of the mPGES-1 inhibitor (benzo[g]indol-3-carboxylate, 3 M) on TNF expression in eWAT explants from WT
and adip mice. Inset, mRNA expression for TNF 48 h after transfection of 3T3-L1 cells with a mPGES-1 siRNA or an universal scrambled negative control
(siCON).D and E, IL-6 andMCP-1 expression in eWAT explants fromWT andadipmice. F, IL-6 andMCP-1 expression inWT fat explants incubatedwith vehicle
(0.2%DMSO), SC-236 (COX-2 inhibitor), SC-260 (COX-1 inhibitor), CJ-016 (5-LO inhibitor), and a combination of SC-236 and CJ-016. Results are themean	 S.E.
*, p
 0.05; **, p
 0.001 with respect to vehicle or WT mice. a, p
 0.05 versus siCON.
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in WAT by direct stimulation of the conversion of pre-adi-
pocytes into beige/brite adipocytes.
An interesting aspect of our study is thatwe provide evidence
of the existence of a coordinate functional regulation of brown-
in-white adipogenesis by mPGES-1 and PPAR. Indeed, our
study presents a number of findings supporting a negative reg-
ulation between the nuclear receptor PPAR and the PGE2 bio-
synthetic pathway (Fig. 7). On one hand, mice deficient in
PPAR specifically in adipose tissue showed increased expres-
sion of COX-2 and mPGES-1 and augmented PGE2 levels. We
noted that elevations in COX-2 expression were more evident
in ex vivo experiments (fat explants cultured in the absence of
circulatory factors) than in vivo. This is probably related to the
existence of complex mechanisms regulating COX-2 in vivo
that may mask the effects of PPAR deletion on adipose tissue
COX-2 expression (34). Indeed, a number of circulating factors
has been reported to exert opposite and counter-regulatory
roles on adipose tissue COX-2 expression, including angioten-
sin II and glucocorticoids (down-regulating) and TNF and
IL-1 (up-regulating) (35, 36). On the other hand, exogenous
PGE2 was able to suppress PPAR expression, whereas oppo-
site effects were seen after inhibition of endogenous PGE2 bio-
synthesis in adipose tissue fromWTmice. The existence of this
negative regulatory loop is consistent with previous studies
showing that pre-adipocytes stably transfected with either
COX-1 or COX-2 had lower PPAR expression (16) and that
mice genetically deficient for mPGES-1 had basal elevations in
PPAR expression and transcriptional activity (17). Moreover,
our results are suggestive of the existence of a positive feedback
loop between PGE2 and local COX-2 andmPGES-1 expression
in adipose tissue (Fig. 7). This finding is consistent with a pre-
viously described positive feedback loop between PGE2 and
mPGES-1 in the porcine endometrium (37) and between PGE2
and COX-2 in abdominal WAT (38).
Our findings indicate that the end result of the coordinate
functional regulation betweenCOX-2/mPGES-1/PGE2 and the
nuclear receptor PPAR is the blockage of differentiation of
pre-adipocytes into mature white adipocytes and the concom-
itant rise of beige/brite adipocytes. The mechanisms by which
the COX-2/mPGES-1/PGE2 axis and the nuclear receptor
PPAR interact during the process of adipogenesis are not
completely delineated but might be related to the ability of
PGE2 to increase intracellular cAMP, which is a well known
mediator of the induction of “brown fat-like” cells residing in
the WAT (7, 8). Another mechanism potentially implicated is
the stabilization of several dominant transcriptional regulators
of white-to-brown adipocyte development and function,
including PRDM16 (9, 11, 38). In fact, our results demonstrate
a reduction in PRDM16 in adipocytes incubated with an inhib-
itor of mPGES-1 activity or transfected with a siRNA that
induce gene silencing of this terminal PG synthase. In any
event, our findings indicate that this process requires the integ-
rity of both systems because PGE2 is not able to inhibit white
adipocyte differentiation in the absence of a PPAR agonist.
Moreover, PGE2 is able to directly induce the browning of
WAT (i.e. UCP1) in WT mice but not in mice lacking PPAR
specifically in adipocytes. Finally, the existence of a loop
between PGE2 and PPAR in the regulation of adipocyte
browning appears not to be a generalized event to all fat depots.
In this regard, adip mice showed more UCP1 expression in
eWATand less expression in iBAT thanWTanimals. Although
the mechanisms underlying this observation are unknown, a
remarkable reduction of UCP1 expression in interscapular, but
not in perigonadal adipose tissue has been previously described
in adip mice (39).
In addition to regulating adipogenesis, PGs are well known
lipid mediators that reproduce the cardinal signs of inflamma-
tion (40). PGs are formed through the sequential actions of
COXs and a variety of terminal PG synthases, which are
expressed with some tissue specificity (41). Among the differ-
ent PGs, PGE2 is themost abundant and closely associated with
inflammatory conditions and is synthesized by the concerted
action of COXs and PGE synthases. In particular, mPGES-1 is
preferentially linked with inducible COX-2, which is then cou-
pled with inflammatory conditions in a variety of cells and tis-
sues (13). On the other hand, PPAR is a ligand-activated tran-
scription factor implicated in the regulation of inflammatory
responses and a nuclear factor assisting the resolution of
inflammation (42). Therefore, it was pertinent in our study to
assess the inflammatory status in adipose tissue frommice spe-
cifically lacking PPAR in this tissue. Our findings showing
increased proinflammatory adipokine expression (i.e. TNF-,
IL-6, and MCP-1) in fat from PPAR knock-out mice further
support the previously described anti-inflammatory role of this
nuclear receptor (42). Our findings also show that either phar-
macological or genetic inhibition of mPGES-1 results in a
reduction of TNF- expression in adipose tissue from WT
mice, a response that was not significantly different from that
seen in PPAR KO mice. This observation suggests that con-
trary to the adipogenic process, there is no coordinate func-
tional regulation between mPGES-1 and PPAR in the control
of adipose tissue inflammation. Considering the duality of
FIGURE 7. Schematic diagram of the proposed coordinated functional
regulation of mPGES-1 and PPAR in beige/brite adipogenesis. PPAR
deletion in WAT uncovers a negative regulation of COX-2 and mPGES-1
expressionby this nuclear receptor. In addition, PGE2 is able todown-regulate
PPARexpression inWAT. Furthermore, in this tissue the interactionbetween
PGE2 and PPAR has the ability to divert pre-adipocyte differentiation from
white into beige/brite adipocytes. Interestingly, PGE2 exerts a PPAR-inde-
pendent positive feedback loopwith local COX-2 andmPGES-1 expression in
adipose tissue.
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PGE2 in WAT where it promotes the browning and heat dissi-
pating function of adipocytes in parallel with a causative
responsibility in adipose inflammation, further studies are
needed to fully elucidate the overall role of theCOX-2/mPGES-
1/PGE2 pathway on the insulin axis and the development or
prevention of obesity-related co-morbidities.
In conclusion, the present study demonstrates the existence
of a functional interaction betweenPPAR andmPGES-1 in the
process of adipogenesis, especially in the formation of beige/
brite adipocytes fromWAT pre-adipocytes. The PGE2-mediated
actions on pre-adipocyte differentiation are notmirrored by other
lipidmediators such as LTB4. Finally, our findings suggest that the
coordinate functional interaction between PPAR and mPGES-1
does not appear to contribute to the regulation of the unbalanced
inflammatory tone associated with obesity.
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